It is common knowledge that androgens play a role in the production of red blood cells. The lack of androgens cause the hematocrit (proportion of blood volume that is occupied by red blood cells) level to fall in most men with prostate cancer who are on a hormone blockade. About 10% of men on a [...]
When we make treatment decisions we never know how effective the treatment will actually be for each individual and for how long that treatment effect might last. This makes all of our treatment decisions guess work. A recent study has demonstrated that counting circulating tumor cells in the blood can be used to predict prostate [...]
Hair on a man's head offers clues about versatility of a molecule central to Advanced Prostate Cancer. Once again, those of us fighting advanced and recurrent prostate cancer are confronted with contradictory and confusing information. The usual first line treatment for advanced prostate cancer is hormone therapy (ADT). We all know that ADT is short [...]
A recent Finnish study released interim results comparing intermittent androgen deprivation (IAD) to continuous androgen deprivation (CAD) in 856 men. All the men had locally advanced or metastatic prostate cancer and they all were treated at 27 clinics in Finland. The period of study was between 1997 and 2003 and all men were required to [...]
I want to tell you about a man named Joel who started hormone therapy (ADT) and could not remember who he was, or were he lived. He was brought up in born in New York City and lived the majority of his life in the city. He never took taxis, but almost always relied on [...]